Polycystic Ovary Syndrome: Challenges and Possible Solutions

J Clin Med. 2023 Feb 14;12(4):1500. doi: 10.3390/jcm12041500.

Abstract

Polycystic ovary syndrome (PCOS) is one of the most common endocrine disorders in women of reproductive age. This syndrome not only impairs female fertility but also increases the risk of obesity, diabetes, dyslipidemia, cardiovascular diseases, psychological diseases, and other health problems. Additionality, because of the high clinical heterogeneity, the current pathogenesis of PCOS is still unclear. There is still a large gap in precise diagnosis and individualized treatment. We summarize the present findings concerning the genetics, epigenetics, gut microbiota, corticolimbic brain responses, and metabolomics of the PCOS pathogenesis mechanism, highlight the remaining challenges in PCOS phenotyping and potential treatment approaches, and explain the vicious circle of intergenerational transmission of PCOS, which might provide more thoughts for better PCOS management in the future.

Keywords: pathogenesis; phenotype; polycystic ovary syndrome; treatment.

Grants and funding

This research was funded by the National Natural Science Foundation of China (8217030752), the Promotion foundation of the National project in Renji Hospital Affiliated to Shanghai Jiaotong University School of Medicine (RJTJ23-ZD-005), the Science and Technology Committee of Shanghai Foundation (18411968700), and Bethune Charitable Foundation (J202103E006).